Key Focus:
GENE + CELL
THERAPY
Powering Gene & Cell Therapy with Next-Gen Sequencing
At AUGenomics, we provide the genomic insights needed to push the boundaries of gene and cell therapy. As a trusted third-party next-generation sequencing (NGS) service provider, we equip researchers and biotech innovators with precise, scalable tools to accelerate therapeutic development.
From vector design and validation to patient-specific profiling, our NGS solutions support every stage of the gene and cell therapy pipeline. We enable deep characterization of genomic edits, transgene integration, off-target effects, and immune responses—delivering the confidence required for safe and effective therapies.
01
Verify CRISPR and gene editing accuracy
02
Track vector integration and transduction efficiency
03
Analyze T-cell receptor (TCR) and CAR-T constructs
04
Monitor clonal expansion and treatment persistence
Accelerating Research and Discovery
Next-generation sequencing (NGS) has ushered in a transformative era for cell and gene therapy by providing comprehensive insights into the molecular intricacies of therapeutic interventions. NGS technologies play a pivotal role in characterizing the genetic profile of both therapeutic cells and target tissues, ensuring precision in the design and implementation of cell and gene therapies. The ability to sequence entire genomes or specific genetic regions enables researchers and clinicians to identify potential genetic abnormalities, confirm the integration of therapeutic genes, and monitor the persistence of modified cells in patients over time. This deep genomic understanding contributes to the optimization of therapeutic strategies, enhances the safety profile of treatments, and facilitates the development of personalized approaches. Moreover, NGS has become instrumental in quality control processes, ensuring the consistency and reliability of cell and gene therapy products. The integration of NGS in this field has accelerated advancements, bringing us closer to realizing the full potential of these innovative therapeutic modalities for a diverse range of diseases.
Let’s Work Together
Get in touch so we can start working together.
